Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Aggarwal

Showing results (1-10 of 280) with videos related to

Pageof 28
Sort By:
Nature|April 12, 2018
Demand cancer drugs that truly help patientsAjay Aggarwal
The Lancet. Oncology|June 2, 2024
Can a Major Conditions Strategy substitute for a National Cancer Control Plan?Ajay Aggarwal, Richard Sullivan
Journal of Clinical and Diagnostic Research : JCDR|September 13, 2017
Short Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label StudyAjay Aggarwal, Roopak Wadhwa
The Journal of the Association of Physicians of India|October 12, 2007
Insulin therapy for patients with type 1 diabetesEesh Bhatia, Ajay Aggarwal
Nature Reviews. Clinical Oncology|February 10, 2016
Health policy: Putting a price on cancerRichard Sullivan, Ajay Aggarwal
British Journal of Cancer|February 9, 2021
Early cancer diagnosis: reaching targets across whole populations amidst setbacksValerie McCormack, Ajay Aggarwal
BMJ (Clinical Research Ed.)|February 15, 2023
Proposal to scrap England's long term plan for cancerRichard Sullivan, Ajay Aggarwal
Journal of Cancer Policy|August 28, 2025
Mapping the global oncology & policy research landscapeAjay Aggarwal, Richard Sullivan
Journal of Orthopaedic Trauma|April 20, 2004
Bilateral spontaneous periacetabular fracture: an unusual complication of multiple sclerosisAjay Aggarwal, Javad Parvizi, Reinhold Ganz
BMJ (Clinical Research Ed.)|February 12, 2026
England's national cancer plan is more of a commercial strategy than a health policyBernard Rachet, Ajay Aggarwal, Martin McKee
Pageof 28

Showing results (1-10 of 280) with videos related to

Sort By:
Pageof 28
Nature|April 12, 2018
Demand cancer drugs that truly help patientsAjay Aggarwal
The Lancet. Oncology|June 2, 2024
Can a Major Conditions Strategy substitute for a National Cancer Control Plan?Ajay Aggarwal, Richard Sullivan
Journal of Clinical and Diagnostic Research : JCDR|September 13, 2017
Short Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label StudyAjay Aggarwal, Roopak Wadhwa
The Journal of the Association of Physicians of India|October 12, 2007
Insulin therapy for patients with type 1 diabetesEesh Bhatia, Ajay Aggarwal
Nature Reviews. Clinical Oncology|February 10, 2016
Health policy: Putting a price on cancerRichard Sullivan, Ajay Aggarwal
British Journal of Cancer|February 9, 2021
Early cancer diagnosis: reaching targets across whole populations amidst setbacksValerie McCormack, Ajay Aggarwal
BMJ (Clinical Research Ed.)|February 15, 2023
Proposal to scrap England's long term plan for cancerRichard Sullivan, Ajay Aggarwal
Journal of Cancer Policy|August 28, 2025
Mapping the global oncology & policy research landscapeAjay Aggarwal, Richard Sullivan
Journal of Orthopaedic Trauma|April 20, 2004
Bilateral spontaneous periacetabular fracture: an unusual complication of multiple sclerosisAjay Aggarwal, Javad Parvizi, Reinhold Ganz
BMJ (Clinical Research Ed.)|February 12, 2026
England's national cancer plan is more of a commercial strategy than a health policyBernard Rachet, Ajay Aggarwal, Martin McKee
Pageof 28